# Trade Mark Journal No.2026/027 3 July 2026

## WO0000001923527 (42)

Office of origin: United States of America

Date of International Registration:3 March 2026
Date of designation in the UK: 3 March 2026

International priority date claimed: 3 September 2025 (United States of America) (99372568)

Class 42
  Medical research services for measuring positive predictive value for cancer screening and for high resolution cancer screening and risk stratification; providing online non-downloadable software using artificial intelligence (AI) and machine learning for analyzing positive predictive value for cancer; providing online non-downloadable software using artificial intelligence (AI) and machine learning for high resolution cancer screening and risk stratification.

Harbinger Health, Inc.

Representative: Christina M. Licursi Wolf, Greenfield & Sacks, P.C., 600 Atlantic Avenue, Boston MA 02210-2206, UNITED STATES OF AMERICA